Volume 14, Number 3—March 2008
Research
Multicenter Cross-Sectional Study of Nontuberculous Mycobacterial Infections among Cystic Fibrosis Patients, Israel
Isaac Levy*1, Galia Grisaru-Soen*12, Liat Lerner-Geva†, Eitan Kerem‡, Hana Blau§, Lea Bentur¶, Micha Aviram#, Joseph Rivlin**, Elie Picard††, Anita Lavy‡‡, Yakov Yahav*, and Galia Rahav*
Table 1
Number of patients in all medical centers and their reasons for exclusion from study
| Center | Total no. patients | Absence of mycobacterial culture (%) | Age <5 y | Other causes* | No. patients included |
|---|---|---|---|---|---|
| A | 134 | 36 (27) | 5 | 11 | 82 |
| B | 82 | 74 (90) | 7 | 1 | 0 |
| C | 75 | 28 (37) | 13 | 3 | 31 |
| D | 71 | 14 (20) | 14 | 1 | 42 |
| E | 60 | 26 (43) | 14 | 2 | 18 |
| F | 31 | 17 (55) | 4 | 2 | 8 |
| G | 15 | 8 (54) | 2 | 0 | 5 |
| Total | 468 | 203 (72) | 59 (21%) | 20 (7%) | 186 |
*Other causes, lung transplantation, immunosuppressive therapy, dropped from follow-up.
1These authors contributed equally to this work.
2Current affiliation: Dana Children's Hospital, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.
Page created: July 07, 2010
Page updated: July 07, 2010
Page reviewed: July 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.